Key result
Latent TGF-beta localizes abundantly in embryonic extracellular matrix, while active TGF-beta distribution remains markedly restricted.
Why the study?
There is little evidence for the existence of latent transforming growth factor-β in vivo and its distribution in embryonic hearts is unclear.
Answers are grounded in this paper and cite their sources.
Embryonic cardiac segments secrete latent TGF-β3 with limited active form in ECM; leaves open whether targeted activation regulates developmental signaling in vivo.
Transforming growth factor-p (TGF-p) is an important regulator of development.In vitro, TGF-P is secreted in a latent, inactive form and can be activated by pH extremes, chaotropic agents, or cell-surface proteases.However, there is little evidence for the existence of latent TGF-f3 in vivo.In this study, we determined whether (1) cultured embryonic cardiac segments secrete latent or active TGF-p, (2) binding of TGF-f3 antibody to TGF-f3 was conformation-dependent (i.e., active vs. latent), and (3) immunostaining of embryonic hearts changed after exposure to activating conditions.Only latent TGF-P3 (acid activatable) was detected in conditioned medium of stage 14-16 chick cardiac segments as measured by a growth inhibition bioassay.No growth-inhibitory activity was present in nonacidified control medium.When blotted onto a membrane, only transiently acidified conditioned medium bound TGF-f3 antibody.These data showed that cardiac segments secrete latent TGF-p which binds with antibody if activated.To determine if antibody binding to tissue sections required exposure to TGF-p-activating conditions, stage 14-16 embryos were fixed and sectioned under conditions that maximally retained extracellular matrix (ECM).Under these conditions, immunostaining was found in the myocardium but not in the endocardium or cardiac ECM.Limited immunostaining was found in other areas of the embryo and was always cell-associated.In addition to the above staining, when tissue sections were exposed to TGF-p activating conditions, immunopositive staining was present within most of the embryonic ECM including the cardiac ECM.All immunostaining was blocked by preabsorption with TGF-P3 protein.These data suggest that active TGF-P has a very limited distribution while latent TGF-P is more abundant in embryonic ECM.Therefore, in vivo activation of TGF-P may play an important role in mediating the expression of TGF-p function during development.
No takes yet. Share an insight, caveat, or question.
Ghosh et al. (1996) studied Embryonic heart development. TGF-beta activating conditions (e.g., transient acidification) vs. Nonacidified control medium / physiological conditions was evaluated on Detection of latent vs. active TGF-beta in cardiac tissue and conditioned medium. Active TGF-beta has a very limited distribution, whereas latent TGF-beta is abundantly present in the embryonic extracellular matrix and can be unmasked by activating conditions.
Synapse has enriched 10 related papers. Consider them for comparative context: